「the 20」の検索結果
143件：41～45件目を表示
-
.：J. Ocul. Pharmacol. 1993; 9(4): 373-384. (PMID: 7906296) 3) Tissié, G. et al.：J. Ocul. Pharmacol. Ther. 2002; 18(1): 65-73. (PMID: 11858616) 4) 山本 哲也ほか：日本眼科学会雑誌. 2007; 111(6): 463-472. 5) 川瀬 和秀ほか：日本...
https://www.senju.co.jp/system/files/2024-01/Mikeluna_IF_20240111.pdf -
发表论文 | 研究与开发 | 千寿制药株式会社
zed, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuki Wada2, Kazunori Omatsu2, on behalf of the SJP-0132 clinical study investigators 1: Department of Ophthalmology, Toho University Faculty of...
http://www.senju.co.jp/chinese/rd/thesis/ -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
zed, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuki Wada2, Kazunori Omatsu2, on behalf of the SJP-0132 clinical study investigators 1: Department of Ophthalmology, Toho University Faculty of...
https://www.senju.co.jp/rd/thesis/ -
Presence of Products | Overseas Activities | SENJU Pharmaceutical
Asia Middle East Europe North&South Ameica Asia Korea Brand Name Marketing Authorisation Holder JP Brand Name BRONUCK Taejoon Pharmaceutical Co., Ltd. BRONUCK ALYMUS Taejoon Pharmaceutical Co., Lt
http://www.senju.co.jp/english/global/world.html -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
-0170GlaucomaP3（Japan） SJP-0154Dry eyeP2（Japan） SJP-0049Allergic ConjunctivitisP2（Japan） As of June 2026
http://www.senju.co.jp/english/rd/pipeline.html